BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2012

Mar 12, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2012-03-09

Reporting Person: Sheridan William P (SR VP - CMO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-09	Emp. Stock Option (Right to Buy)	$5.59	A	100000	Acquired	2022-03-09	Common Stock (100000)	Direct

Footnotes

F1: The Award will vest in its entirety three years after the Grant Date.